Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma: A Secondary Analysis of the SWOG S1404 Randomized Clinical Trial
帕博利珠单抗辅助治疗与高剂量干扰素或伊匹木单抗治疗对切除黑色素瘤患者生活质量结局的疗效比较:SWOG S1404随机临床试验的二次分析
期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2022.5486
Unger, Joseph M; Darke, Amy; Othus, Megan; Truong, Thach-Giao; Khushalani, Nikhil; Kendra, Kari; Lewis, Karl D; Faller, Bryan; Funchain, Pauline; Buchbinder, Elizabeth I; Tarhini, Ahmad A; Kirkwood, John M; Sharon, Elad; Sondak, Vernon; Guild, Samantha R; Grossmann, Kenneth; Ribas, Antoni; Patel, Sapna P